{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T21:02:28Z","timestamp":1763154148924,"version":"3.37.3"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jgar.2018.10.022","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T16:31:07Z","timestamp":1541089867000},"page":"242-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Lack of correlation between reduced outpatient consumption of macrolides and macrolide resistance of invasive Streptococcus pneumoniae isolates in Slovenia during 1997\u20132017"],"prefix":"10.1016","volume":"16","author":[{"given":"Tamara","family":"Kastrin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Metka","family":"Paragi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanja","family":"Er\u010dulj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tja\u0161a","family":"\u017dohar \u010cretnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Bajec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"\u010ci\u017eman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2014","series-title":"Surveillance of antimicrobial consumption in Europe 2012","author":"European Centre for Disease Prevention and Control (ECDC)","key":"10.1016\/j.jgar.2018.10.022_bib0005"},{"year":"2017","series-title":"Surveillance of antimicrobial resistance in Europe 2016. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)","author":"European Centre for Disease Prevention and Control (ECDC)","key":"10.1016\/j.jgar.2018.10.022_bib0010"},{"issue":"Suppl 3","key":"10.1016\/j.jgar.2018.10.022_bib0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1469-0691.2009.02725.x","article-title":"Antibiotic consumption and link to resistance","volume":"15","author":"Goossens","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2018.10.022_bib0020","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0924-8579(02)00394-1","article-title":"The use and resistance to antibiotics in the community","volume":"21","author":"Cizman","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2018.10.022_bib0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/jac\/dkp443","article-title":"Reducing antimicrobial resistance in the community by restricting prescribing; can it be done?","volume":"65","author":"Enne","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2018.10.022_bib0030","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijantimicag.2006.07.023","article-title":"Macrolide resistance rates in respiratory pathogens in Slovenia following reduced macrolide use","volume":"28","author":"\u010ci\u017eman","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2018.10.022_bib0035","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJM199708143370701","article-title":"The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance","volume":"337","author":"Sepp\u00e4l\u00e4","year":"1997","journal-title":"N Engl J Med"},{"year":"2016","series-title":"ATC classification index with DDDs 2017","author":"WHO Collaborating Centre for Drug Statistics Methodology","key":"10.1016\/j.jgar.2018.10.022_bib0040"},{"key":"10.1016\/j.jgar.2018.10.022_bib0045","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/00365549709019037","article-title":"Antimicrobial resistance of invasive Streptococcus pneumoniae in Slovenia, 1993\u20131995. The Slovenian Meningitis Study Group","volume":"29","author":"Cizman","year":"1997","journal-title":"Scand J Infect Dis"},{"year":"2012","series-title":"Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement. CLSI document M100-S22","author":"Clinical and Laboratory Standards Institute","key":"10.1016\/j.jgar.2018.10.022_bib0050"},{"key":"10.1016\/j.jgar.2018.10.022_bib0055","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 3.1. http:\/\/www.eucast.org\/clinical_breakpoints. [Accessed 12 February 2019]."},{"key":"10.1016\/j.jgar.2018.10.022_bib0060","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1128\/AAC.40.11.2562","article-title":"Detection of erythromycin-resistant determinants by PCR","volume":"40","author":"Sutcliffe","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.10.022_bib0065","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1128\/JCM.40.3.774-778.2002","article-title":"Macrolide efflux genes mef(A) and mef(E) are carried by different genetic elements in Streptococcus pneumoniae","volume":"40","author":"Del Grosso","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2018.10.022_bib0070","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1099\/00221287-144-11-3049","article-title":"A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease","volume":"144","author":"Enright","year":"1998","journal-title":"Microbiology"},{"year":"2003","series-title":"The analysis of time series. An introduction","author":"Chatfield","key":"10.1016\/j.jgar.2018.10.022_bib0075"},{"key":"10.1016\/j.jgar.2018.10.022_bib0080","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/00006454-199412000-00001","article-title":"Decline of erythromycin resistance of group A streptococci in Japan","volume":"13","author":"Fujiti","year":"1994","journal-title":"Pediatr infect Dis J"},{"key":"10.1016\/j.jgar.2018.10.022_bib0085","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3201\/eid1809.120049","article-title":"Antimicrobial drug use and macrolide-resistant Streptococcus pyogenes, Belgium","volume":"18","author":"Van Heirstraeten","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jgar.2018.10.022_bib0090","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3343\/kjlm.2010.30.5.485","article-title":"Decline in erythromycin resistance in group A streptococci from acute pharyngitis due to changes in the emm genotypes rather than restriction of antibiotic use","volume":"30","author":"Koh","year":"2010","journal-title":"Korean J Lab Med"},{"key":"10.1016\/j.jgar.2018.10.022_bib0095","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1086\/655697","article-title":"The decline of pneumococcal resistance after cessation of mass antibiotic distributions for trachoma","volume":"5","author":"Haug","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2018.10.022_bib0100","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1086\/517809","article-title":"Clonal spread of group A Streptococcus with the new type of erythromycin resistance. Finnish Study Group for Antimicrobial Resistance","volume":"177","author":"Kataja","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2018.10.022_bib0105","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/infdis\/jiu552","article-title":"Evidence for clonal expansion after antibiotic selection pressure: pneumococcal multilocus sequence types before and after mass azithromycin treatments","volume":"211","author":"Keenan","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2018.10.022_bib0110","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jac\/dkn202","article-title":"Macrolide resistance among invasive Streptococcus pneumoniae in Slovenia","volume":"62","author":"Kastrin","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2018.10.022_bib0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/mdr.2006.9994","article-title":"Rapid spread in Norway of an erythromycin-resistant pneumococcal clone, despite low usage of macrolides","volume":"13","author":"Sogstad","year":"2007","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jgar.2018.10.022_bib0120","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1128\/AAC.49.7.2903-2913.2005","article-title":"Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003","volume":"49","author":"Reinert","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 3A","key":"10.1016\/j.jgar.2018.10.022_bib0125","first-page":"3S","article-title":"Streptococcus pneumoniae: epidemiology and patterns of resistance","volume":"117","author":"Jacobs","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.jgar.2018.10.022_bib0130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jinf.2007.04.006","article-title":"Regional trends in \u03b2-lactam, macrolide, fluoroquinolone and telithromycin resistance among Streptococcus pneumoniae isolates 2001\u20132004","volume":"55","author":"Felmingham","year":"2007","journal-title":"J Infect"},{"key":"10.1016\/j.jgar.2018.10.022_bib0135","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1128\/JCM.41.9.4194-4216.2003","article-title":"Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction","volume":"41","author":"Gertz","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2018.10.022_bib0140","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1128\/JCM.39.7.2565-2571.2001","article-title":"Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network","volume":"39","author":"McGee","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2018.10.022_bib0145","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1128\/AAC.01453-06","article-title":"Clonal spread of mef-positive macrolide-resistant Streptococcus pneumoniae isolates causing invasive disease in adults in Germany","volume":"51","author":"van der Linden","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.10.022_bib0150","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jac\/dkh551","article-title":"Evolution of erythromycin resistance in Streptococcus pneumoniae in Italy","volume":"55","author":"Monaco","year":"2005","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371651830211X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371651830211X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T11:42:35Z","timestamp":1565264555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221371651830211X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":30,"alternative-id":["S221371651830211X"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2018.10.022","relation":{},"ISSN":["2213-7165"],"issn-type":[{"type":"print","value":"2213-7165"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lack of correlation between reduced outpatient consumption of macrolides and macrolide resistance of invasive Streptococcus pneumoniae isolates in Slovenia during 1997\u20132017","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2018.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}